The Medical Science Liaison (MSL), Oncology (Head & Neck Cancers) will join a fast-growing Field Medical Affairs team focused on commercializing the novel Signatera™ molecular residual disease (MRD) test. This role focuses on supporting oncologists and cancer researchers across solid tumors—with a specific emphasis on head and neck cancers—alongside complementary products and services within Natera’s oncology portfolio. In 2019, the FDA designated Signatera as a Breakthrough Device, and Medicare proposed coverage for its use in patients with Stage II–III colorectal cancer as its first indication. We are seeking a mission-oriented Medical Affairs professional who can communicate effectively to help transform the management of cancer worldwide. The MSL serves as a primary field-based scientific resource for clinicians, academic institutions, and professional organizations.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Number of Employees
501-1,000 employees